COMPANY
Catena Biosciences
Funding and NIH signals
- NIH award NIH awarded $1.07M (SBIR Phase II 1R44CA314761-01, new, notice Sep 17, 2026). NIH RePORTER 1R44CA314761-01 (Sep 17, 2026)
Evidence (1 event)
- Sep 17, 2026 · NIH RePORTER 1R44CA314761-01
Organization: CATENA BIOSCIENCES, INC.; City/State: EL CERRITO, CA; Project number: 1R44CA314761-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 1072102; Administering IC: National Cancer Institute; Project title: Advancing Site-Selective Multi-Payload HER2-Targeted Conjugates to Overcome Resistance and Boost Survival in Breast and Gastric Cancers; Organization type: Domestic For-Profits
- Sep 17, 2026 · NIH RePORTER 1R44CA314761-01